The impact of informatics and computational chemistry on synthesis and screening

Drug Discovery Today

Volumn 6, Issue 21, 2001, Pages 1101-1110

  Manly, Charles J ^a   Louise May, Shirley ^a   Hammer, Jack D ^a  

^a NEUROGEN CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; DRUG ABSORPTION; DRUG INDUSTRY; DRUG METABOLISM; DRUG SCREENING; DRUG SOLUBILITY; DRUG SYNTHESIS; DRUG TARGETING; EXPERIMENTAL MODEL; GASTROINTESTINAL ABSORPTION; GENE TARGETING; INFORMATION SCIENCE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; TOXICITY;

EID: 0035498999     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(01)01990-0     Document Type: Review

References (87)

1. Virtual screening - An overview
2. Mining for medicines - In silico
3. Large-scale virtual screening for discovering leads in the postgenomic era
4. Integrating virtual screening methods to the quest for novel membrane protein ligands
5. Industrial-scale genomics-based drug design and discovery
6. The in silico world of virtual libraries
7. Chemoinformatics - A new name for an old problem?
8. Optimization of chemical libraries by neural networks
9. Lead compounds discovered from libraries
10. In silico research in drug discovery
11. Diversity screening versus focused screening in drug discovery
12. Approaches to virtual library design
13. Recognizing molecules with drug-like properties
14. E Pluribus product: How can we optimize selection of drug development candidates from many compounds at an early stage?
15. Avoiding investment in doomed drugs. Is poor solubility an industry wide problem?
16. High-throughput approaches for evaluating absorption, distribution, metabolism and excretion properties of lead compounds
17. Pharmacokinetics and metabolism in early drug discovery
18. Computational methods for the prediction of 'drug-likeness'
19. ADMET/PK as part of a rational approach to drug discovery
20. Predicting human safety: Screening and computational approaches
21. Toward designing drug-like libraries: A novel computational approach for prediction of drug feasibility of compounds
22. Progress in predicting human ADME parameters in silico
23. RECAP - Retrosynthetic combinatorial analysis procedure: A powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry
24. PLUMS: A program for the rapid optimization of focused libraries
25. The design of leadlike combinatorial libraries
26. Optimization of the biological activity of combinatorial compound libraries by a genetic algorithm
27. Beyond mere diversity: Tailoring combinatorial libraries for drug discovery
28. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases
29. Comments on the design of chemical libraries for screening
30. Experimental and computational approaches to estimate solubility and permeability in drug discovery and developmental settings
31. Use of statistical and neural net methods in predicting toxicity of chemicals: A hierarchical QSAR approach
32. Molecular descriptors in chemoinformatics, computational combinatorial chemistry and virtual screening
33. New QSAR methods applied to structure-activity mapping and combinatorial chemistry
34. On computing the nearest neighbor interchange distance
35. Improved heterogeneous distance functions
36. Prospective identification of biologically active substructures by topomer similarity searching
37. Toward general methods of targeted library design: Topomer shape similarity searching with diverse structures as queries
38. 50 values for ACAT inhibitors from molecular structure
39. Classification of kinase inhibitors using BCUT descriptors
40. Automated pharmacophore identification for large chemical data sets
41. Selected concepts and investigations in compound classification, molecular descriptor analysis and virtual screening
42. Extraction of pharmacophore information from high-throughput screens
43. Multivariate adaptive regression splines
44. Molecular data mining tool: Advances in HIV research
45. An alternative to neural nets: Multivariate adaptive regression splines (MARS)
46. Use of automatic relevance determination in QSAR studies using bayesian neural networks
47. Clustering of large databases of compounds: Using the MDL 'Keys' as structural descriptors
48. The information content of 2D and 3D structural descriptors relevant to ligand-receptor binding
49. Validated descriptors for diversity measurements and optimization
50. Molecular hashkeys: A novel method for molecular characterization and its application for predicting important pharmaceutical properties of molecules
51. The EVA spectral descriptor
52. A widely applicable set of descriptors
53. Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties
54. Prediction of drug absorption using multivariate statistics
55. Prediction of polar surface area and drug transport processes using simple parameters and PLS statistics
56. New 4-point pharmacophore method for molecular similarity and diversity applications: Overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures
57. Designing libraries with CNS activity
58. Molecular complexity and its impact on the probability of finding leads for drug discovery
59. Implementation of a system for reagent selection and library enumeration, profiling and design
60. Virtual combinatorial syntheses and computational screening of new potential anti-herpes compounds
61. Analysis of a large structure/biological activity data set using recursive partitioning
62. Lipophilicity in PK design: Methyl, ethyl, futile
63. Prediction of properties from simulations: Free energies of solvation in hexadecane, octanol, and water
64. Prediction of aqueous solubility of organic compounds from molecular structure
65. Prediction of solvation free energies of small organic molecules: Additive-constitutive models based on molecular fingerprints and atomic constants
66. Neural network modeling for estimation of the aqueous solubility of structurally related drugs
67. Evaluation of dynamic polar molecular surface area as predictor of drug absorption: Comparison with other computational and experimental predictors
68. Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs
69. Polar molecular surface properties predict the intestinal absorption of drugs in humans
70. Prediction of the intestinal absorption of endothelin receptor antagonists using three theoretical methods of increasing complexity
71. Prediction of human intestinal absorption of drug compounds from molecular structure
72. A novel approach to predicting P450 mediated drug metabolism. CYP2D6 catalyzed N-dealkylation reactions and qualitative metabolite predictions using a combined protein and pharmacophore model for CYP2D6
73. Three-dimensional-quantitative structure activity relationship analysis of cytochrome P-450 3A4 substrates
74. Prediction of drug half-life values of antihistamines based on the CODES/neural network model
75. QT interval prolongation by non-cardiovascular drugs: Issues and solutions for novel drug development
76. QT interval prolongation by noncardiovascular drugs: A proposed assessment strategy
77. + channels by the novel blocker PD85639
78. Study of structure-toxicity relationship by a counterpropagation neural network
79. Compass: A shape-based machine learning tool for drug design
80. Quantitative binding site model generation: Compass applied to multiple chemotypes targeting the 5-HT1a receptor
81. Construction of 3D-QSAR models using the 4D-QSAR analysis formalism
82. High-throughput and virtual screening: Core lead discovery technologies move towards integration
83. Genomics: Saviour or millstone?